Safety and efficacy of nivolumab combined with chemotherapy and targeted therapy in patients with relapsed/refractory classical Hodgkin lymphoma
Latest Information Update: 22 Jul 2020
At a glance
- Drugs Nivolumab (Primary) ; Bendamustine; Brentuximab vedotin; Gemcitabine; Vinblastine
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association